End-of-day quote
Korea S.E.
23:00:00 09/05/2024 BST
|
5-day change
|
1st Jan Change
|
4,265
KRW
|
+1.55%
|
|
+12.83%
|
+0.12%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
57,030
|
87,666
|
73,531
|
99,093
|
80,357
|
308,937
|
Enterprise Value (EV)
1 |
64,645
|
97,148
|
97,086
|
121,176
|
97,493
|
342,257
|
P/E ratio
|
51.6
x
|
101
x
|
-10.1
x
|
31.3
x
|
14.5
x
|
-125
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.28
x
|
1.83
x
|
1.33
x
|
1.41
x
|
0.9
x
|
3.34
x
|
EV / Revenue
|
1.45
x
|
2.03
x
|
1.76
x
|
1.72
x
|
1.09
x
|
3.7
x
|
EV / EBITDA
|
20
x
|
21.2
x
|
-98.1
x
|
19.1
x
|
7.42
x
|
43.7
x
|
EV / FCF
|
-34.8
x
|
313
x
|
-23.8
x
|
-14.7
x
|
-46
x
|
-13
x
|
FCF Yield
|
-2.87%
|
0.32%
|
-4.21%
|
-6.79%
|
-2.17%
|
-7.68%
|
Price to Book
|
1.82
x
|
2.35
x
|
2.22
x
|
2.25
x
|
1.34
x
|
3.47
x
|
Nbr of stocks (in thousands)
|
44,209
|
48,976
|
51,782
|
56,624
|
58,020
|
72,520
|
Reference price
2 |
1,290
|
1,790
|
1,420
|
1,750
|
1,385
|
4,260
|
Announcement Date
|
19/03/19
|
20/03/20
|
23/03/21
|
22/03/22
|
22/03/23
|
19/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
44,714
|
47,845
|
55,268
|
70,277
|
89,481
|
92,439
|
EBITDA
1 |
3,237
|
4,586
|
-990.1
|
6,335
|
13,143
|
7,830
|
EBIT
1 |
1,572
|
1,398
|
-5,490
|
759
|
6,639
|
-148.8
|
Operating Margin
|
3.52%
|
2.92%
|
-9.93%
|
1.08%
|
7.42%
|
-0.16%
|
Earnings before Tax (EBT)
1 |
1,380
|
1,140
|
-6,869
|
2,903
|
5,227
|
-852
|
Net income
1 |
1,246
|
944.6
|
-7,230
|
4,038
|
5,972
|
-2,248
|
Net margin
|
2.79%
|
1.97%
|
-13.08%
|
5.75%
|
6.67%
|
-2.43%
|
EPS
2 |
25.00
|
17.64
|
-141.0
|
55.97
|
95.64
|
-34.00
|
Free Cash Flow
1 |
-1,855
|
310.6
|
-4,087
|
-8,226
|
-2,118
|
-26,288
|
FCF margin
|
-4.15%
|
0.65%
|
-7.4%
|
-11.7%
|
-2.37%
|
-28.44%
|
FCF Conversion (EBITDA)
|
-
|
6.77%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
32.88%
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19/03/19
|
20/03/20
|
23/03/21
|
22/03/22
|
22/03/23
|
19/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
7,615
|
9,481
|
23,555
|
22,083
|
17,136
|
33,320
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.353
x
|
2.067
x
|
-23.79
x
|
3.486
x
|
1.304
x
|
4.255
x
|
Free Cash Flow
1 |
-1,855
|
311
|
-4,087
|
-8,226
|
-2,118
|
-26,288
|
ROE (net income / shareholders' equity)
|
4.31%
|
2.75%
|
-22.3%
|
10.2%
|
11.4%
|
-2.86%
|
ROA (Net income/ Total Assets)
|
2.11%
|
1.45%
|
-4.22%
|
0.51%
|
3.87%
|
-0.07%
|
Assets
1 |
59,155
|
65,267
|
171,482
|
790,534
|
154,484
|
3,443,241
|
Book Value Per Share
2 |
709.0
|
763.0
|
639.0
|
779.0
|
1,032
|
1,227
|
Cash Flow per Share
2 |
40.60
|
278.0
|
302.0
|
189.0
|
239.0
|
178.0
|
Capex
1 |
2,939
|
3,176
|
6,394
|
4,486
|
7,130
|
9,457
|
Capex / Sales
|
6.57%
|
6.64%
|
11.57%
|
6.38%
|
7.97%
|
10.23%
|
Announcement Date
|
19/03/19
|
20/03/20
|
23/03/21
|
22/03/22
|
22/03/23
|
19/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +0.12% | 230M | | -4.01% | 14.91B | | -35.44% | 2.96B | | -14.59% | 2.41B | | -11.01% | 1.48B | | -.--% | 1.12B | | +58.24% | 583M | | +94.87% | 515M | | +12.77% | 244M | | +4.07% | 188M |
Medical Imaging Systems
|